ABSTRACT

Fact Sheet for Healthcare Providers: Compass Laboratory Services SARS-CoV2 Assay - Compass Laboratory Services, LLC   [open pdf - 90KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Compass Laboratory Services SARS-CoV2 [severe acute respiratory syndrome coronavirus 2] Assay that has been issued an Emergency Use Authorization (EUA) by FDA. The Compass Laboratory Services SARS-CoV2 Assay is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 [coronavirus disease 2019] by their healthcare provider or self-collected using a home collection kit specified in the test's labeling."

Publisher:
Date:
2020-07-13
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations